Jian Xie

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Letter by Qin et al Regarding Article "Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure".

Letter by Qin et al Regarding Article "Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure".

Journal: Circulation

Published: June 01, 2026

Letter by Liu et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".

Letter by Liu et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".

Journal: Circulation

Published: September 08, 2025

Integrated expression quantitative trait loci and Mendelian randomization analyses of the candidate genes and pathways identified for myocardial infarction.

Integrated expression quantitative trait loci and Mendelian randomization analyses of the candidate genes and pathways identified for myocardial infarction.

Journal: Frontiers in molecular biosciences

Published: August 26, 2025

Inhibition of super-enhancer-driven lncRNA SHC alleviates coronary microembolization-induced myocardial injury by inhibiting cardiac ferroptosis.

Inhibition of super-enhancer-driven lncRNA SHC alleviates coronary microembolization-induced myocardial injury by inhibiting cardiac ferroptosis.

Journal: European journal of pharmacology

Published: June 25, 2025

Identification and verification of biomarkers associated with neutrophils in acute myocardial infarction: integrated analysis of bulk RNA-seq, expression quantitative trait loci, and mendelian randomization.

Identification and verification of biomarkers associated with neutrophils in acute myocardial infarction: integrated analysis of bulk RNA-seq, expression quantitative trait loci, and mendelian randomization.

Journal: Frontiers in molecular biosciences

Published: April 18, 2025

Macrophage Polarization in Myocardial Ischemia‒Reperfusion Injury: Pathophysiology and Therapeutic Targets.

Macrophage Polarization in Myocardial Ischemia‒Reperfusion Injury: Pathophysiology and Therapeutic Targets.

Journal: Drug design, development and therapy

Published: January 07, 2025

Comprehensive analysis of hypoxia-related genes in diagnosis and immune infiltration in acute myocardial infarction: based on bulk and single-cell RNA sequencing data.

Comprehensive analysis of hypoxia-related genes in diagnosis and immune infiltration in acute myocardial infarction: based on bulk and single-cell RNA sequencing data.

Journal: Frontiers in molecular biosciences

Published: June 14, 2024

Identification of mitochondria-related gene biomarkers associated with immune infiltration in acute myocardial infarction.

Identification of mitochondria-related gene biomarkers associated with immune infiltration in acute myocardial infarction.

Journal: iScience

Published: February 11, 2024

Metabolomic insights into Monascus-fermented rice products: Implications for monacolin K content and nutritional optimization.

Metabolomic insights into Monascus-fermented rice products: Implications for monacolin K content and nutritional optimization.

Journal: Food science & nutrition

Published: January 25, 2024

Application of angiogenesis-related genes associated with immune infiltration in the molecular typing and diagnosis of acute myocardial infarction.

Application of angiogenesis-related genes associated with immune infiltration in the molecular typing and diagnosis of acute myocardial infarction.

Journal: Aging

Published: November 24, 2023

Ferroptosis in cardiovascular disease.

Ferroptosis in cardiovascular disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 28, 2023

Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway.

Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway.

Journal: Frontiers in pharmacology

Published: September 29, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026